Literature DB >> 9684725

Myopotential sensing by a dual chamber implantable cardioverter defibrillator: two case reports.

P Deshmukh1, K Anderson.   

Abstract

INTRODUCTION: Inappropriate discharges and/or improper inhibition of bradycardia pacing due to oversensing of extraneous signals in implantable cardioverter defibrillators (ICDs) have been described. With one exception, no previous report involving an intact lead system has cited myopotential oversensing as the cause. METHODS AND
RESULTS: Two case reports of myopotential oversensing by a dual chamber ICD system are reported. In the first patient suffering from chronic pulmonary obstructive disease, intermittent myopotential sensing during labored respiration resulted in episodic inhibition of bradycardia pacing. In the second patient, oversensing of sustained myopotentials generated during strenuous isometric activity resulted in an inappropriate ICD discharge. For both, the ICD system consisted of a CPI model 1810 Ventak AV used in conjunction with a model 0125 Endotak lead, incorporating integrated bipolar sensing.
CONCLUSION: Although modern ICDs have proven to be highly effective in detecting and terminating malignant tachyarrhythmias, the opportunity for improving their detection specificity remains.

Entities:  

Mesh:

Year:  1998        PMID: 9684725     DOI: 10.1111/j.1540-8167.1998.tb00964.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

Review 1.  Implantable dual-chamber cardioverter-defibrillator-pacemaker.

Authors:  D Pfeiffer; M Mende; A Hagendorff
Journal:  Curr Cardiol Rep       Date:  2000-07       Impact factor: 2.931

2.  Inappropriate arrhythmia detection in implantable defibrillator therapy due to oversensing of diaphragmatic myopotentials.

Authors:  B Schulte; J Sperzel; J Carlsson; M Dürsch; A Erdogan; H F Pitschner; J Neuzner
Journal:  J Interv Card Electrophysiol       Date:  2001-12       Impact factor: 1.900

3.  Dual chamber implantable cardioverter defibrillator benefits and limitations.

Authors:  K Fan; K Lee; C P Lau
Journal:  J Interv Card Electrophysiol       Date:  1999-10       Impact factor: 1.900

4.  Unmasking of myopotential oversensing by an integrated bipolar defibrillator lead following AV node ablation.

Authors:  M Dorenkamp; L-H Boldt; F Blaschke; Y Kühnle; W Haverkamp; M Roser
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-06

5.  Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators.

Authors:  Mohammad Saeed; Anna Jin; Gregory Pontone; Steve Higgins; Michael Gold; David Harari; Steven Nunley; Mark S Link; Munther K Homoud; N A Mark Estes; Paul J Wang
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-07       Impact factor: 1.468

Review 6.  Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?

Authors:  K L Lee; C P Lau
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

7.  A fortuitous syncope. The pitfalls of integrated bipolar defibrillator leads.

Authors:  Tushar V Salukhe; Ian Wright; Matthew Wright; Prapa Kanagaratnam; Mark D O'Neill
Journal:  Indian Pacing Electrophysiol J       Date:  2008-11-01

8.  Inappropriate Shock delivered by Implantable Cardioverter Defibrillator--Cardiac Resynchronization Therapy (ICD-CRT) due to myopotential oversensing.

Authors:  Hamid Barakpour; Zahra Emkanjoo; Abolfath Alizadeh; Mohammad Ali Sadr-Ameli
Journal:  Indian Pacing Electrophysiol J       Date:  2009-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.